Suppr超能文献

日本脓毒症管理指南。

The Japanese guidelines for the management of sepsis.

机构信息

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-Ku, Chiba 260-8677 Japan.

Department of Emergency Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295 Japan.

出版信息

J Intensive Care. 2014 Oct 28;2(1):55. doi: 10.1186/s40560-014-0055-2. eCollection 2014.

Abstract

This is a guideline for the management of sepsis, developed by the Sepsis Registry Committee of The Japanese Society of Intensive Care Medicine (JSICM) launched in March 2007. This guideline was developed on the basis of evidence-based medicine and focuses on unique treatments in Japan that have not been included in the Surviving Sepsis Campaign guidelines (SSCG), as well as treatments that are viewed differently in Japan and in Western countries. Although the methods in this guideline conform to the 2008 SSCG, the Japanese literature and the results of the Sepsis Registry Survey, which was performed twice by the Sepsis Registry Committee in intensive care units (ICUs) registered with JSICM, are also referred. This is the first and original guideline for sepsis in Japan and is expected to be properly used in daily clinical practice. This article is translated from Japanese, originally published as "The Japanese Guidelines for the Management of Sepsis" in the Journal of the Japanese Society of Intensive Care Medicine (J Jpn Soc Intensive Care Med), 2013; 20:124-73. The original work is at http://dx.doi.org/10.3918/jsicm.20.124.

摘要

这是 2007 年 3 月成立的日本重症医学会(JSICM)Sepsis 登记委员会制定的脓毒症管理指南。本指南是基于循证医学制定的,重点介绍了日本特有的、未被《拯救脓毒症运动指南》(SSCG)收录的治疗方法,以及日本与西方国家在治疗方法上存在差异的地方。尽管本指南的方法符合 2008 年 SSCG,但也参考了日本文献和 Sepsis 登记委员会在重症监护病房(ICUs)进行的两次 Sepsis 登记调查的结果,该委员会在 JSICM 注册。这是日本脓毒症的首个原始指南,预计将在日常临床实践中得到妥善应用。本文由日本重症医学会出版的《日本脓毒症管理指南》翻译而来,该杂志于 2013 年发表,20:124-73。原文可在 http://dx.doi.org/10.3918/jsicm.20.124. 查阅。

相似文献

1
The Japanese guidelines for the management of sepsis.
J Intensive Care. 2014 Oct 28;2(1):55. doi: 10.1186/s40560-014-0055-2. eCollection 2014.
2
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).
J Intensive Care. 2018 Feb 2;6:7. doi: 10.1186/s40560-017-0270-8. eCollection 2018.
3
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).
J Intensive Care. 2021 Aug 25;9(1):53. doi: 10.1186/s40560-021-00555-7.
4
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).
Acute Med Surg. 2021 Aug 26;8(1):e659. doi: 10.1002/ams2.659. eCollection 2021 Jan-Dec.
5
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).
Acute Med Surg. 2018 Feb 5;5(1):3-89. doi: 10.1002/ams2.322. eCollection 2018 Jan.
6
The clinical practice guideline for the management of ARDS in Japan.
J Intensive Care. 2017 Jul 25;5:50. doi: 10.1186/s40560-017-0222-3. eCollection 2017.
7
9
A multicenter, prospective evaluation of quality of care and mortality in Japan based on the Surviving Sepsis Campaign guidelines.
J Infect Chemother. 2014 Feb;20(2):115-20. doi: 10.1016/j.jiac.2013.09.003. Epub 2013 Dec 11.
10
Japanese Clinical Practice Guidelines for Rehabilitation in Critically Ill Patients 2023 (J-ReCIP 2023).
J Intensive Care. 2023 Nov 7;11(1):47. doi: 10.1186/s40560-023-00697-w.

引用本文的文献

2
Carbapenem Usage in the Initial Antibiotic Therapy of Sepsis in Japanese Intensive Care Units.
Cureus. 2025 Jan 11;17(1):e77271. doi: 10.7759/cureus.77271. eCollection 2025 Jan.
3
Subphenotypes of platelet count trajectories in sepsis from multi-center ICU data.
Sci Rep. 2024 Aug 30;14(1):20187. doi: 10.1038/s41598-024-71186-9.
4
Impact of the FilmArray Rapid Multiplex PCR Assay on Clinical Outcomes of Patients with Bacteremia.
Diagnostics (Basel). 2023 Jun 1;13(11):1935. doi: 10.3390/diagnostics13111935.
6
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).
Acute Med Surg. 2021 Aug 26;8(1):e659. doi: 10.1002/ams2.659. eCollection 2021 Jan-Dec.
7
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).
J Intensive Care. 2021 Aug 25;9(1):53. doi: 10.1186/s40560-021-00555-7.
8
The Early Diagnostic Efficacy of Serum Histone H3 in Rabbit Urosepsis Model.
Biomed Res Int. 2021 Jul 16;2021:9969344. doi: 10.1155/2021/9969344. eCollection 2021.

本文引用的文献

1
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.
Cochrane Database Syst Rev. 2013 Sep 16;2013(9):CD001090. doi: 10.1002/14651858.CD001090.pub2.
3
Acute respiratory distress syndrome: the Berlin Definition.
JAMA. 2012 Jun 20;307(23):2526-33. doi: 10.1001/jama.2012.5669.
6
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Clin Infect Dis. 2012 Mar 1;54(5):621-9. doi: 10.1093/cid/cir895. Epub 2012 Jan 12.
8
Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*.
Crit Care Med. 2012 Mar;40(3):725-30. doi: 10.1097/CCM.0b013e31823778ee.
9
Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury.
JAMA. 2011 Oct 12;306(14):1574-81. doi: 10.1001/jama.2011.1435. Epub 2011 Oct 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验